These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

193 related articles for article (PubMed ID: 10431671)

  • 1. Selective inflammatory effect of systemic fluorouracil in actinic keratosis.
    Nabai H; Mohindra R; Mehregan D
    Cutis; 1999 Jul; 64(1):43-4. PubMed ID: 10431671
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inflammation of actinic keratoses with capecitabine therapy for colon cancer.
    Serrão VV; Feio AB
    Eur J Dermatol; 2008; 18(2):200. PubMed ID: 18424393
    [No Abstract]   [Full Text] [Related]  

  • 3. Inflammation of actinic keratoses and acral erythrodysesthesia during capecitabine treatment.
    Peramiquel L; Dalmau J; Puig L; Roé E; Fernández-Figueras MT; Alomar A
    J Am Acad Dermatol; 2006 Nov; 55(5 Suppl):S119-20. PubMed ID: 17052530
    [No Abstract]   [Full Text] [Related]  

  • 4. Effect of a 1-week treatment with 0.5% topical fluorouracil on occurrence of actinic keratosis after cryosurgery: a randomized, vehicle-controlled clinical trial.
    Jorizzo J; Weiss J; Furst K; VandePol C; Levy SF
    Arch Dermatol; 2004 Jul; 140(7):813-6. PubMed ID: 15262691
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A pharmacokinetic evaluation of 0.5% and 5% fluorouracil topical cream in patients with actinic keratosis.
    Levy S; Furst K; Chern W
    Clin Ther; 2001 Jun; 23(6):908-20. PubMed ID: 11440290
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Randomized trial evaluating a new 0.5% fluorouracil formulation demonstrates efficacy after 1-, 2-, or 4-week treatment in patients with actinic keratosis.
    Jorizzo J; Stewart D; Bucko A; Davis SA; Espy P; Hino P; Rodriguez D; Savin R; Stough D; Furst K; Connolly M; Levy S
    Cutis; 2002 Dec; 70(6):335-9. PubMed ID: 12502122
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cutaneous recall reactions with systemic fluorouracil.
    Kirkup ME; Narayan S; Kennedy CT
    Dermatology; 2003; 206(2):175-6. PubMed ID: 12592090
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The use of topical fluorouracil to treat actinic keratosis.
    Robins P; Gupta AK
    Cutis; 2002 Aug; 70(2 Suppl):4-7. PubMed ID: 12353679
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Adherence to a topical regimen of 5-fluorouracil, 0.5%, cream for the treatment of actinic keratoses.
    Yentzer B; Hick J; Williams L; Inabinet R; Wilson R; Camacho FT; Russell GB; Feldman SR
    Arch Dermatol; 2009 Feb; 145(2):203-5. PubMed ID: 19221274
    [No Abstract]   [Full Text] [Related]  

  • 10. Inflammation of solar keratoses following systemic 5-fluorouracil.
    Bataille V; Cunningham D; Mansi J; Mortimer P
    Br J Dermatol; 1996 Sep; 135(3):478-80. PubMed ID: 8949450
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Systemic toxicity from occlusive therapy with topical 5-fluorouracil: a case report and review of the literature.
    Sargen M; Wanat KA; Jambusaria A; Rosenbach M; Sobanko J; Miller CJ
    Dermatol Surg; 2012 Oct; 38(10):1756-9. PubMed ID: 22805044
    [No Abstract]   [Full Text] [Related]  

  • 12. Effective treatment of actinic keratosis with 0.5% fluorouracil cream for 1, 2, or 4 weeks.
    Weiss J; Menter A; Hevia O; Jones T; Ling M; Rist T; Roberts J; Shavin JS; Sklar J; Webster G; Connolly M; Furst K; Levy S
    Cutis; 2002 Aug; 70(2 Suppl):22-9. PubMed ID: 12353677
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Topical therapy for actinic keratoses, I: 5-Fluorouracil and imiquimod.
    Tutrone WD; Saini R; Caglar S; Weinberg JM; Crespo J
    Cutis; 2003 May; 71(5):365-70. PubMed ID: 12769403
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Fluorouracil 5% and 0.5% creams for the treatment of actinic keratosis: equivalent efficacy with a lower concentration and more convenient dosing schedule.
    Jorizzo JL; Carney PS; Ko WT; Robins P; Weinkle SH; Werschler WP
    Cutis; 2004 Dec; 74(6 Suppl):18-23. PubMed ID: 15666898
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Topical 5-fluorouracil for the treatment of periocular actinic keratosis and low-grade squamous malignancy.
    Couch SM; Custer PL
    Ophthalmic Plast Reconstr Surg; 2012; 28(3):181-3. PubMed ID: 22460673
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Actinic keratosis and capecitabine therapy.
    Higa GM; Kovach RF; Abraham J
    J Oncol Pharm Pract; 2005 Dec; 11(4):151-3. PubMed ID: 16595067
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cicatricial Ectropion With Topical 5% Fluorouracil Cream.
    Tsui M; Tajirian A
    Dermatol Surg; 2016 Aug; 42(8):1005-6. PubMed ID: 27191780
    [No Abstract]   [Full Text] [Related]  

  • 18. Selective cytotoxic effect of topical 5-fluorouracil.
    Dillaha CJ; Jansen GT; Honeycutt WM; Bradford AC
    Arch Dermatol; 1983 Sep; 119(9):774-83. PubMed ID: 6614965
    [TBL] [Abstract][Full Text] [Related]  

  • 19. One-week treatment with 0.5% fluorouracil cream prior to cryosurgery in patients with actinic keratoses: a double-blind, vehicle-controlled, long-term study.
    Jorizzo J; Weiss J; Vamvakias G
    J Drugs Dermatol; 2006 Feb; 5(2):133-9. PubMed ID: 16485881
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Treatment of lip keratoses (actinic cheilitis) with topical fluorouracil.
    Epstein E
    Arch Dermatol; 1977 Jul; 113(7):906-8. PubMed ID: 879810
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.